SNTI NASDAQ
Senti Biosciences, Inc.
1W: -2.1%
1M: -5.7%
3M: -70.2%
YTD: -70.7%
1Y: -77.6%
3Y: -93.3%
5Y: -99.7%
$0.32
-0.00 (-0.65%)
Weekly Expected Move ±7.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
29 relationships29
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-05-28
Earliest Filing
2025-03-24
Latest Filing
investor: 18
partner: 7
customer: 2
target: 2
Counterparties (Filed by SNTI)
29 relationshipsCompanies named in SNTI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners LLC | — | partner | Sales agent for at-the-market offering program | 2025-03-24 | View |
| New Enterprise Associates, Inc. | — | investor | Venture capital firm and investor affiliated with entities purchasing Series A Preferred Stock and Warrants. | 2024-12-02 | View |
| Bayer Healthcare, LLC | — | investor | Institutional investment fund affiliated with entities purchasing Series A Preferred Stock and Warrants. | 2024-12-02 | View |
| Celadon Partners SPV 24 | — | investor | Investor entity entering into a Designation Agreement to appoint a director to the Board. | 2024-12-02 | View |
| New Enterprise Associates 15, L.P. | — | investor | Investor entity entering into a Designation Agreement to appoint a director to the Board. | 2024-12-02 | View |
| Britannia Biotech Gateway Limited Partnership | — | partner | Landlord whose consent is required for the sublease term | 2024-09-27 | View |
| JLSA2 Therapeutics, Inc. | — | customer | Subtenant in a sublease agreement for corporate headquarters space | 2024-09-27 | View |
| BKPBIOTECH, Inc. | — | customer | Subtenant in a sublease agreement for corporate headquarters space | 2024-09-27 | View |
| Valere Bio, Inc. | — | partner | Parent company of GeneFab that co-acquired assets and provided seller economic share consideration. | 2023-08-10 | View |
| Celadon Partners, LLC | — | investor | Company that manages Valere Bio, Inc., the parent of the acquiring entity GeneFab. | 2023-08-10 | View |
| GeneFab, LLC | — | partner | Acquired assets and intellectual property from Senti Biosciences and entered into a development and manufacturing servic | 2023-08-10 | View |
| Chardan Capital Markets LLC | — | investor | Entered into a Common Stock Purchase Agreement and Registration Rights Agreement to provide a committed equity facility | 2022-09-01 | View |
| NEA Ventures 2018, L.P. | — | investor | PIPE Investor affiliated with NEA | 2022-06-15 | View |
| Bayer Healthcare LLC | — | investor | Invested via Convertible Note Exchange and PIPE Investment | 2022-06-15 | View |
| LifeForce Capital | — | investor | PIPE Investor with unfunded commitment | 2022-06-15 | View |
| Dynamics Sponsor LLC | — | investor | Sponsor entity and PIPE Investor | 2022-06-15 | View |
| 8VC Fund I, L.P. | — | investor | PIPE Investor affiliated with 8VC | 2022-06-15 | View |
| 8VC Entrepreneurs Fund I, L.P. | — | investor | PIPE Investor affiliated with 8VC | 2022-06-15 | View |
| New Enterprise Associates 15, L.P. | — | investor | PIPE Investor affiliated with NEA | 2022-06-15 | View |
| Senti Biosciences, Inc. | SNTI | target | Target company in the proposed merger with Dynamics Special Purpose Corp. | 2022-02-15 | View |
| Explore Merger Sub, Inc. | — | partner | Merger Sub entity involved in the Business Combination Agreement | 2022-02-15 | View |
| Senti Biosciences, Inc. | SNTI | target | Target company in the business combination agreement to be acquired by Dynamics Special Purpose Corp. | 2021-12-20 | View |
| ARK Investment Management LLC | — | investor | Investor party to the Non-Redemption Agreement. | 2021-12-20 | View |
| The Invus Group, LLC | — | investor | Investor party to the Non-Redemption Agreement. | 2021-12-20 | View |
| T. Rowe Price Group, Inc. | — | investor | Investor party to the Non-Redemption Agreement. | 2021-12-20 | View |
| Morgan Stanley Investment Management Inc. | MS-PL | investor | Investor party to the Non-Redemption Agreement. | 2021-12-20 | View |
| Explore Merger Sub, Inc. | — | partner | Merger subsidiary formed to merge with Senti Biosciences Inc. | 2021-12-20 | View |
| Dynamics Sponsor LLC | — | investor | Purchaser of private placement shares and sponsor | 2021-05-28 | View |
| Fintech Acquisition LLC | — | partner | Counterparty to the letter agreement regarding business combination | 2021-05-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-24 | Officer/Director Change | View | |
| 2026-09-04 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-09-02 | Material Agreement; Delisting Notice | Agreement | View |
| 2026-08-20 | Material Agreement; Financial Obligation | Agreement | View |
| 2026-07-15 | Material Agreement; Earnings Release; Change in Control; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-05-26 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-05-14 | Earnings Release; Other Events; Exhibits | View | |
| 2026-05-01 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Change in Control; Exhibits | Agreement | View |
| 2026-04-24 | Material Agreement; Termination of Agreement; Delisting Notice; Change in Control; Officer/Director | Agreement | View |
| 2026-04-01 | Other Events | View | |
| 2026-03-27 | Earnings Release; Exhibits | View | |
| 2025-12-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-18 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-06-30 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-18 | Regulation FD Disclosure; Other Events | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-28 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-03-24 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR